Martin Homering
Leverkusen, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin.
Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin.
Journal: Thrombosis research
Published: April 04, 2018
Risk of recurrent venous thromboembolism according to baseline risk factor profiles.
Journal: Blood advances
Published: February 08, 2018
Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty.
Journal: Vascular health and risk management
Published: April 08, 2014
Allogeneic blood transfusions and postoperative infections after total hip or knee arthroplasty.
Journal: The Journal of bone and joint surgery. American volume
Published: February 21, 2014
D-dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients: a subanalysis of the randomized controlled MAGELLAN trial.
Journal: Journal of thrombosis and haemostasis : JTH
Published: July 16, 2013
Complication rates after hip or knee arthroplasty in morbidly obese patients.
Journal: Clinical orthopaedics and related research
Published: December 19, 2012
Incidence of neuraxial haematoma after total hip or knee surgery: RECORD programme (rivaroxaban vs. enoxaparin).
Journal: Acta anaesthesiologica Scandinavica
Published: December 17, 2012
The effects of rivaroxaban on the complications of surgery after total hip or knee replacement: results from the RECORD programme.
Journal: The Journal of bone and joint surgery. British volume
Published: October 31, 2012
Concomitant use of medication with antiplatelet effects in patients receiving either rivaroxaban or enoxaparin after total hip or knee arthroplasty.
Journal: Thrombosis research
Published: October 14, 2011
Showing 1-10 of 10
Last Updated: 09/26/2026